tenk.fyi

Enliven Therapeutics, Inc.

ELVNNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$103.7M

16.5% YoY

EPS

$-1.83

3.2% YoY

Cash

$98.9M

20.3% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade